These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 23243947)

  • 1. [Severe tricyclic antidepressants poisoning--a case study].
    Zapalska-Pozarowska K; Szponar J; Tchórz M; Kostek H; Pozarowski W
    Przegl Lek; 2012; 69(8):621-3. PubMed ID: 23243947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tricyclic antidepressants, QT interval prolongation, and torsade de pointes.
    Vieweg WV; Wood MA
    Psychosomatics; 2004; 45(5):371-7. PubMed ID: 15345781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses.
    Friberg LE; Isbister GK; Duffull SB
    Br J Clin Pharmacol; 2006 Feb; 61(2):177-90. PubMed ID: 16433872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
    Othong R; Devlin JJ; Kazzi ZN
    Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diphenhydramine induced QT prolongation and torsade de pointes: An uncommon effect of a common drug.
    Husain Z; Hussain K; Nair R; Steinman R
    Cardiol J; 2010; 17(5):509-11. PubMed ID: 20865683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of torsades de pointes induced by severe QT prolongation after an overdose of eperisone and triazolam in a patient receiving nifedipine.
    Yamagiwa T; Amino M; Morita S; Yamamoto R; Saito T; Inokuchi S
    Clin Toxicol (Phila); 2010 Feb; 48(2):149-52. PubMed ID: 20199131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for QT prolongation associated with acute psychotropic drug overdose.
    Miura N; Saito T; Taira T; Umebachi R; Inokuchi S
    Am J Emerg Med; 2015 Feb; 33(2):142-9. PubMed ID: 25445869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram.
    Berling I; Isbister GK
    Ann Emerg Med; 2015 Aug; 66(2):154-64. PubMed ID: 25639523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.
    Isbister GK; Balit CR; Macleod D; Duffull SB
    J Clin Psychopharmacol; 2010 Aug; 30(4):391-5. PubMed ID: 20531221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug induced QT prolongation].
    Altmann D; Eggmann U; Ammann P
    Wien Klin Wochenschr; 2008; 120(5-6):128-35. PubMed ID: 18365152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
    Sala M; Coppa F; Cappucciati C; Brambilla P; d'Allio G; Caverzasi E; Barale F; De Ferrari GM
    Curr Opin Investig Drugs; 2006 Mar; 7(3):256-63. PubMed ID: 16555686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Torsade de pointes].
    Haverkamp W; Hördt M; Chen X; Hindricks G; Willems S; Kottkamp H; Rotman B; Brunn J; Borggrefe M; Breithardt G
    Z Kardiol; 1993 Dec; 82(12):763-74. PubMed ID: 8147050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long QT syndrome and torsades de pointes induced by acute sulpiride poisoning.
    Chang JH; Weng TI; Fang CC
    Am J Emerg Med; 2009 Oct; 27(8):1016.e1-3. PubMed ID: 19857426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amiodarone therapy after sotalol-induced torsade de pointes: prolonged QT interval and QT dispersion in differentiation of pro-arrhythmic effects].
    van de Loo A; Klingenheben T; Hohnloser SH
    Z Kardiol; 1994 Dec; 83(12):887-90. PubMed ID: 7846927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
    Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terlipressin-induced ventricular arrhythmia.
    Urge J; Sincl F; Procházka V; Urbánek K
    Scand J Gastroenterol; 2008; 43(9):1145-8. PubMed ID: 18609153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P; Hreiche R; Turgeon J
    Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics of 52 patients with torsade de points associated with acquired QT prolongation].
    Song L; Yang YM; Zhu J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Apr; 39(4):293-6. PubMed ID: 21624301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.